Proton beam therapy in pediatric oncology

Cancer Journal

Volumn 15, Issue 4, 2009, Pages 298-305

  Merchant, Thomas E ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

Brain tumors; Neuroblastoma; Pediatrics; Proton beam therapy; Sarcoma

Indexed keywords

CHILD; CHILDHOOD CANCER; CRANIOPHARYNGIOMA; DOSIMETRY; EPENDYMOMA; GLIOMA; HODGKIN DISEASE; HUMAN; MEDULLOBLASTOMA; NASOPHARYNX CANCER; PRIORITY JOURNAL; PROTON THERAPY; RETINOBLASTOMA; REVIEW;

AGE FACTORS; BRAIN NEOPLASMS; CENTRAL NERVOUS SYSTEM NEOPLASMS; CHILD; DOSE-RESPONSE RELATIONSHIP, RADIATION; HUMANS; NEUROBLASTOMA; PROTONS; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; SARCOMA; TREATMENT OUTCOME;

EID: 69549114794     PISSN: 15289117     EISSN: 1540336X     Source Type: Journal    
DOI: 10.1097/PPO.0b013e3181b6d4b7     Document Type: Review

References (30)

1. ICRU Report 50. Prescribing, Recording and Reporting Photon Beam Therapy. Washington D.C: International Commission on Radiation Units and Measurements; 1992.
2. ICRU Report 62. Prescribing, Recording and Reporting Photon Beam Therapy (Supplement to ICRO Report 50). Washington D.C: International Commission on Radiation Units and Measurements; 1999.
3. ICRU Report 78. Prescribing, Recording and Reporting Proton-Beam Therapy. Washington D.C: International Commission on Radiation Units and Measurements; 2007.
4. http://www.demographia.com/db-ua2000pop.htm.
5. Hug EB, Sweeney RA, Nurre PM, et al. Proton radiotherapy in management of pediatric base of skull tumors. Int J Radiat Oncol Biol Phys. 2002;52:1017-1024. (Pubitemid 34219022)
6. Dendale R, Lumbroso-Le Rouic L, Noel G, et al. Proton beam radiotherapy for uveal melanoma: results of Curie Institut-Orsay proton therapy center (ICPO). Int J Radiat Oncol Biol Phys. 2006;65:780-787. (Pubitemid 43795817)
7. Slater JD, Rossi CJ Jr, Yonemoto LT, et al. Proton therapy for prostate cancer: the initial Loma Linda University experience. Int J Radiat Oncol Biol Phys. 2004;59:348-352. (Pubitemid 38622585)
8. Merchant TE, Kiehna EN, Li C, et al. Radiation dosimetry predicts IQ after conformal radiation therapy in pediatric patients with localized ependymoma. Int J Radiat Oncol Biol Phys. 2005;63:1546-1554. (Pubitemid 41628055)
9. Merchant TE, Kiehna EN, Li C, et al. Modeling radiation dosimetry to predict cognitive outcomes in pediatric patients with CNS embryonal tumors including medulloblastoma. Int J Radiat Oncol Biol Phys. 2006;65:210-221.
10. Merchant TE, Goloubeva O, Pritchard DL, et al. Radiation dose-volume effects on growth hormone secretion. Int J Radiat Oncol Biol Phys. 2002;52:1264-1270. (Pubitemid 34296487)
11. Krasin MJ, Xiong A, Wu S, et al. The effects of external beam irradiation on the growth of flat bones in children: modeling a dose-volume effect. Int J Radiation Oncology Biol Phys. 2005;62:1458-1463. (Pubitemid 40982070)
12. Krengli M, Hug EB, Adams JA, et al. Proton radiation therapy for retinoblastoma: comparison of various intraocular tumor locations and beam arrangements. Int J Radiat Oncol Biol Phys. 2005;61:583-593. (Pubitemid 40164456)
13. Kozak KR, Adams J, Krejcarek SJ, et al. A dosimetric comparison of proton and intensity-modulated photon radiotherapy for pediatric parameningeal rhabdomyosarcomas. Int J Radiat Oncol Biol Phys. 2009;74:179-186.
14. Lee CT, Bilton SD, Famiglietti RM, et al. Treatment planning with protons for pediatric retinoblastoma, medulloblastoma, and pelvic sarcoma: how do protons compare with other conformal techniques? Int J Radiat Oncol Biol Phys. 2005;63:362-372.
15. Merchant TE, Hua CH, Shukla H, et al. Proton versus photon radiotherapy for common pediatric brain tumors: comparison of models of dose characteristics and their relationship to cognitive function. Pediatr Blood Cancer. 2008;51:110-117. (Pubitemid 351717400)
16. MacDonald SM, Safai S, Trofimov A, et al. Proton radiotherapy for childhood ependymoma: initial clinical outcomes and dose comparisons. Int J Radiat Oncol Biol Phys. 2008;71:979-986.
17. CBTRUS. Statistical Report: Primary Brain Tumors in the United States, 1995-1999. Hinsdale, IL: Central Brain Tumor Registry of the United States; 2002.
18. Mulhern RK, Merchant TE, Gajjar A, et al. Late neurocognitive sequelae among survivors of pediatric brain tumors. Lancet Oncol. 2004;5:399-408.
19. Merchant TE, Mulhern RK, Krasin MJ, et al. Preliminary results from a phase II trial of conformal radiation therapy and the evaluation of radiation-related CNS effects for pediatric patients with localized ependymoma. J Clin Oncol. 2004;22:3156-3162.
20. Conklin HM, Li C, Xiong X, et al. Predicting change in academic abilities after conformal radiation therapy for localized ependymoma. J Clin Oncol. 2008;26:3965-3970.
21. Merchant TE, Lee H, Zhu J, et al. The effects of hydrocephalus on intelligence quotient in children with localized infratentorial ependymoma before and after focal radiation therapy. J Neurosurg. 2004;101(2 suppl):159-168. (Pubitemid 39426189)
22. Hua C, Bass JK, Khan RB, et al. Hearing loss after radiotherapy for pediatric brain tumors: effect of cochlea dose. Int J Radiat Oncol Biol Phys. 2008;72:892-899.
23. Merchant TE, Conklin HM, Wu S, et al. Late effects of conformal radiation therapy for pediatric patients with low-grade glioma: prospective evaluation of cognitive, endocrine and hearing deficits. J Clin Oncol. In press.
24. Habrand JL, Saran F, Alapetite C, et al. Radiation therapy in the management of craniopharyngioma: current concepts and future developments. J Pediatr Endocrinol Metab. 2006;19(suppl 1):389-394.
25. Merchant TE. Central nervous system tumors in children. In: Gunderson L, Tepper J, eds. Clinical Radiation Oncology. 2nd ed. Philadelphia, PA: Elsevier; 2007:1575-1591.
26. Walter AW, Mulhern RK, Gajjar A, et al. Survival and neurodevelopmental outcome of young children with medulloblastoma at St Jude Children's Research Hospital. J Clin Oncol. 1999;17:3720-3728.
27. Ris MD, Packer R, Goldwein J, et al. Intellectual outcome after reduced-dose radiation therapy plus adjuvant chemotherapy for medulloblastoma: a Children's Cancer Group study. J Clin Oncol. 2001;19:3470-3476. (Pubitemid 32730083)
28. Merchant TE, Kun LE, Krasin MJ, et al. A multi-institution prospective trial of reduced-dose craniospinal irradiation (23.4 Gy) followed by conformal posterior fossa (36 Gy) and primary site irradiation (55.8 Gy) and dose-intensive chemotherapy for average-risk medulloblastoma. Int J Radiat Oncol Biol Phys. 2008;70:782-787.
29. Mulhern RK, Palmer SL, Merchant TE, et al. Neurocognitive consequences of risk-adapted therapy for childhood medulloblastoma. J Clin Oncol. 2005;23:5511-5519.
30. Newhauser WD, Fontenot JD, Mahajan A, et al. The risk of developing a second cancer after receiving craniospinal proton irradiation. Phys Med Biol. 2009;54:2277-2291.